ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

MXCN Maxcyte Inc

680.00
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Maxcyte Inc MXCN London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 680.00 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
680.00 680.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202407:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
02/4/202407:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
12/3/202415:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202415:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
09/2/202407:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
30/1/202407:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
23/1/202407:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
08/1/202415:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
03/1/202407:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
02/1/202401:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
11/12/202315:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
16/11/202307:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
08/11/202315:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
06/11/202315:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
04/10/202315:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..
06/9/202307:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Executive Vice..
05/9/202307:05GLOBEMaxCyte to Participate in Baird Global Healthcare Conference
09/8/202315:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2023 Financial..
01/8/202307:05GLOBEMaxCyte Signs Strategic Platform License with Prime Medicine..
13/7/202307:05GLOBEMaxCyte to Report Second Quarter 2023 Financial Results on..
10/7/202307:05GLOBEMaxCyte and Vittoria Biotherapeutics Sign Strategic Platform..
06/7/202307:05GLOBEMaxCyte Signs Strategic Platform License with Lyell..
01/6/202315:05GLOBEMaxCyte to Participate in Upcoming Investor Conferences
10/5/202315:05GLOBEMaxCyte Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock